Skip to main content
. 2023 Jun 13;381:e074684. doi: 10.1136/bmj-2022-074684

Fig 1.

Fig 1

Crude annual breast cancer mortality rates and cumulative breast cancer mortality risks in 512 447 women with early breast cancer by time since diagnosis according to calendar period of diagnosis: for all women (top panel), for women aged 50-64 years (who would all have been eligible for screening) according to whether their cancer was screen detected (middle panels), and according to oestrogen receptor (ER) status (bottom panel). Vertical lines are 95% confidence intervals. Numbers of women at risk, numbers of deaths from breast cancer, annual rates, and cumulative mortality risks are given in tables S4 to S6. Further analyses of women by ER status are in figures S4 and S5. Analyses of non-breast cancer mortality and all cause mortality are in figures S23 and S24. Analyses of women with metastatic as well as early breast cancer, and including women who received neoadjuvant therapy, are in figure S25